Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes - Wikidata - wikimedia - TriplyDB

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes

http://www.wikidata.org/entity/Q34320945

about

Critical evaluation of ceftolozane-tazobactam for complicated urinary tract and intra-abdominal infections Resistant pathogens, fungi, and viruses.High-throughput and automated diagnosis of antimicrobial resistance using a cost-effective cellphone-based micro-plate reader.Retrospective analysis of fosfomycin combinational therapy for sepsis caused by carbapenem-resistant Klebsiella pneumoniae.Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae.Resistance to Colistin in Klebsiella Pneumoniae: A 4.0 Strain?Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae.Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens.Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance.Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae Triethysilyl Enol Ethers in the Synthesis of Carbapenem Precursors.Assessment of combination therapy in BALB/c mice injected with carbapenem-resistant Enterobacteriaceae strains Step-Wise Increase in Tigecycline Resistance in Klebsiella pneumoniae Associated with Mutations in ramR, lon and rpsJ A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome.Efficacy of Appropriate Antimicrobial Therapy on the Survival of Patients With Carbapenem Nonsusceptible Klebsiella Pneumoniae Infection: A Multicenter Study in Taiwan.Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae Correlation of β-Lactamase Production and Colistin Resistance among Enterobacteriaceae Isolates from a Global Surveillance Program.Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes.Ceftazidime-Avibactam (Avycaz): For the Treatment of Complicated Intra-Abdominal and Urinary Tract Infections High minimum inhibitory concentration of imipenem as a predictor of fatal outcome in patients with carbapenem non-susceptible Klebsiella pneumoniae Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase.Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.Establishment of Experimental Murine Peritonitis Model with Hog Gastric Mucin for Carbapenem-Resistant Gram-Negative Bacteria.Confronting carbapenemase-producing Klebsiella pneumoniae.Management of Intra-abdominal Infections due to Carbapenemase-Producing Organisms.Genomics of KPC-producing Klebsiella pneumoniae sequence type 512 clone highlights the role of RamR and ribosomal S10 protein mutations in conferring tigecycline resistance.Optimizing Antibiotic Dosing Strategies for the Treatment of Gram-negative Infections in the Era of Resistance.What Is the Appropriate Meropenem MIC for Screening of Carbapenemase-Producing Enterobacteriaceae in Low-Prevalence Settings?Targeting intracellular bacteria with an extended cationic amphiphilic polyproline helix.The Resistance Phenotype and Molecular Epidemiology of Klebsiella pneumoniae in Bloodstream Infections in Shanghai, China, 2012-2015 Therapeutic options for carbapenem-resistant Enterobacteriaceae infections.Updates in the Management of Cephalosporin-Resistant Gram-Negative Bacteria.Emerging Issues and Treatment Strategies in Carbapenem-Resistant Enterobacteriaceae (CRE).Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections.Carbapenem-resistant Enterobacteriaceae in the community: a scoping review.Treatment of sepsis: What is the antibiotic choice in bacteremia due to carbapenem resistant Enterobacteriaceae?

P2860

Q26747429-815B1529-E77D-4365-973A-119BA01B0A67 Q30301237-F9C84C96-7206-48FB-9928-77AA95CE7527 Q33451918-4784537D-5F61-4E11-A732-FAF82C10AB7F Q33597689-63A4FB77-0438-43C7-A8AA-34DC64E21371 Q33798081-A30CD6F5-21B0-47B2-934F-CE41FC0DE315 Q33803459-112549E1-C0BF-4616-A3EF-99EE8C0F912A Q33816251-3EAF09B6-618B-49D5-A3A9-D9F6A62C7B4B Q34336456-2CFF186B-2DFB-4E5B-916B-94C4EAA8713A Q34366895-5685C151-2106-4B8C-80E7-2BD73A71A28F Q34447679-A51ABA58-2789-4427-9B6F-A3E144832766 Q34696364-6C61E4AE-E6B0-4190-90FF-5DA930B899CA Q34922881-41A5AE43-ED92-4851-AAD0-0B6575A5330C Q35167183-36557674-260A-46D5-B902-8CC4E691F1AD Q35664367-41C93216-2779-46D1-98D9-F89BAFDCA2A4 Q36097659-1C839A04-EC65-45C3-99B5-12198620870E Q36169422-A604BC40-D7F1-4F23-80C3-927EBBBFF42F Q36181417-FCA6B13A-9817-41E5-A19B-717F19962223 Q36194091-5098F65C-57A5-4D83-8B4A-C6890CA65D61 Q36274141-488D788D-94AB-4BE0-AE0E-3F962CE0E83C Q36644582-7FC8C0F5-121C-4197-BEE8-1E7C08FB1B91 Q37055016-202CB42A-F330-40B4-9AAF-05207EC9FC10 Q37065167-89F2931C-49E1-448F-A352-261CE1917B0C Q37123365-18C03B92-0CD9-4735-BF4F-88195984AC22 Q37227817-B3E29AF3-8BC9-4AEF-9F0D-7546FE32A79B Q37340068-D3F23D41-AC75-4AD8-AE01-3200D77E94BC Q37648626-451CA57F-519F-47A7-AB8A-9D8B0E40967F Q37739009-5319ABF6-81E0-4325-AC98-03089AA2AA26 Q38135903-498F1033-5230-48D1-88F0-7AE0E750C43F Q38240411-E7F58427-7FC1-4504-BD89-85ACC42915B5 Q38324448-731692A7-3045-40C2-A151-FDCC92269415 Q38672016-5FD1763F-5A12-4170-9B5E-53FFB0718345 Q38741830-47D06446-5E2A-434E-BC94-9483CA2180F8 Q38880898-181E8982-4A1C-48E4-BA9A-B9A515F3263A Q38915940-A19ECF79-3F2F-446C-8AF7-065285A31C67 Q38918458-DA6A6040-55DE-4497-8B4A-4EAA7C4603BF Q38981397-3ED83245-33B7-4BA4-8087-8A8436BE9FC5 Q39031126-4D203280-F377-4F94-B229-A7CAFDA7DF08 Q39292295-F58A6E6D-6BAD-4C3D-B7B6-3D0EFE359EEC Q39396465-5D2EF338-E681-4353-8E96-5017E49024A0 Q40068450-10AE2B64-F227-4BEB-919A-153BBE722DAA

P2860

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes

http://www.wikidata.org/entity/Q34320945

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes

@ast

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes

@en

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes

@nl

type

label

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes

@ast

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes

@en

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes

@nl

prefLabel

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes

@ast

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes

@en

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes

@nl

P1433

Q34320945-436A9829-C20F-4949-A957-1392E4B529FB

P1476

Q34320945-078818EB-393C-4562-B84C-28B081AC134E

P2093

Q34320945-1EC34D95-E314-42D1-BBC8-500F44251CB2

Q34320945-9C78A80C-A69D-4F20-B341-AACFAD3618D7

Q34320945-F68FB01A-59AB-479D-9047-B9E8022EF016

P2860

Q34320945-02B6AC37-CFE7-428B-A263-F3D537DE7D06

Q34320945-0551715E-42C3-4DF5-931D-0F26BAE8C71C

Q34320945-064C0462-0D86-468D-8049-80F7CB22E65C

Q34320945-06C01BA8-5DE3-48A0-B0F4-BC5BBEA479EA

Q34320945-07CDD566-EF8B-4061-9BD4-B0A7AD825259

Q34320945-0A60B6CA-112A-4F00-ACA1-B8E1E84A38BC

Q34320945-0EB2EC71-693A-4B8E-A5E2-446DC1F23B0D

Q34320945-10E1BDFC-1B3F-46F3-9AF5-C0F38D5B5937

Q34320945-13658B21-152D-4300-A7F3-71E6E7E056BA

Q34320945-15D3768D-E4BE-476E-A2C3-78B45610E566

P304

Q34320945-57712DB1-1304-4BD7-B72D-E5DCCD3E6911

P31

Q34320945-827315F7-5EA5-40AE-AA26-14B3098A884F

P356

Q34320945-848CF985-21EC-4E64-AD8D-23E7BD44E1E3

P433

Q34320945-3230E8A6-A708-4D06-A875-D7E72DCDA627

P478

Q34320945-F7F75BD3-1436-41E3-85E8-7C9BE187830D

P50

Q34320945-0C198653-AE18-43EC-952F-AD2D9EDF7178

P577

Q34320945-CBD5E7FA-8A76-4B85-95C8-0BD6CA60F510

P5875

Q34320945-5F09E442-372B-4CE8-AAA4-6F4BB530C495

P698

Q34320945-D53A2358-0AC4-4091-89BD-34B8C9DF7D0B

P921

Q34320945-35224A70-0A6E-4638-A651-177CEED8D408

P932

Q34320945-EF115AAB-6B68-4285-91C8-E49760127E28

P356

J.DIAGMICROBIO.2012.11.009

P1433

Diagnostic Microbiology and Infectious Disease

P1476

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes

@en

P2093

David van Duin

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Neuner

http://www.w3.org/2001/XMLSchema#string

Keith S Kaye

http://www.w3.org/2001/XMLSchema#string

P2860

Combating antimicrobial resistance: policy recommendations to save lives

Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria

The aminoglycosides

Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary.

Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models.

Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.

Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center.

Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa.

Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate.

Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination.

P304

115-120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DIAGMICROBIO.2012.11.009

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P50

Robert A Bonomo

P577

2013-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234069129

http://www.w3.org/2001/XMLSchema#string

P698

23290507

http://www.w3.org/2001/XMLSchema#string

P921

carbapenem antibiotic

P932

3947910

http://www.w3.org/2001/XMLSchema#string